ALGYNOMICS, INC.

Basic Information

208 N. Columbia St., Ste 300
CHAPEL HILL, NC, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 602754017
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of a Novel Class for Opioid Drugs

    Amount: $656,967.00

    DESCRIPTION (provided by applicant): The mu-opioid receptor (MOR) is the primary target for opioid analgesics. While opioids are the most frequently used and effective analgesics for the treatment of ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government